As shown in Table 1, stathmin is highly expressed in a variety of assessed human malignancies including lung cancer [3, 11], esophageal carcinoma [12–16], breast cancer [17], cholangiocarcinoma [18], hepatocellular carcinoma [4, 19, 20], gastric cancer [21–25], pancreatic cancer [26–28], myelodysplastic syndromes [29], nasopharyngeal carcinoma [30], malignant pleural mesothelioma [31], cervical carcinomas [32], endometrial carcinoma [33, 34], urothelial carcinoma of the bladder [35–37], colorectal cancer [38] and glioblastoma [39]. Here, STMN1 is linked to hepatocellular carcinoma.